Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This bill requires physicians in New Jersey to offer to test patients for dihydropyrimidine dehydrogenase deficiency (DPD deficiency) before they begin chemotherapy. DPD deficiency can cause harmful reactions to chemotherapy drugs. The bill also mandates that health insurance plans cover the cost of a single DPD deficiency test annually and any related prescription drug treatments, applying these provisions to various types of health insurance plans including individual, group, small employer, and health maintenance organizations.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours